Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis
NCT02456363
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
300
Enrollment
OTHER
Sponsor class
Conditions
Ankylosing Spondylitis
Interventions
BIOLOGICAL:
TNF alpha
DRUG:
NSAIDs and sulfasalazine
Sponsor
Chung Shan Medical University